Omadacycline

Results: 4



#Item
1Combioxin receives Clinical Trial Authorization to initiate a first-in-man study with CAL02 in patients with severe pneumococcal pneumonia GENEVA, SWITZERLAND, 12 January 2016 – Combioxin SA is pleased to announce that

Combioxin receives Clinical Trial Authorization to initiate a first-in-man study with CAL02 in patients with severe pneumococcal pneumonia GENEVA, SWITZERLAND, 12 January 2016 – Combioxin SA is pleased to announce that

Add to Reading List

Source URL: www.lascco.com

Language: English - Date: 2016-01-12 07:22:29
2Antimicrobial Activity of PTK[removed]Omadacycline) and Comparator Agents Against Contemporary Pathogens Commonly Associated with Community-Acquired Laboratories Respiratory Tract Infections Collected During 2011 from the

Antimicrobial Activity of PTK[removed]Omadacycline) and Comparator Agents Against Contemporary Pathogens Commonly Associated with Community-Acquired Laboratories Respiratory Tract Infections Collected During 2011 from the

Add to Reading List

Source URL: www.paratekpharm.com

Language: English - Date: 2012-10-12 16:04:01
3Omadacycline (PTK796) Mechanism of Action Studies by Using In Vitro Protein Synthesis Inhibition Assay and Molecular Modeling Poster C1-609 Session 87

Omadacycline (PTK796) Mechanism of Action Studies by Using In Vitro Protein Synthesis Inhibition Assay and Molecular Modeling Poster C1-609 Session 87

Add to Reading List

Source URL: www.paratekpharm.com

Language: English - Date: 2012-10-12 16:03:53
4Antimicrobial Activity of PTK[removed]Omadacycline) Tested against Gram-positive Organisms Isolated from European Hospitals in 2011 P1450 ECCMID[removed]HS SADER, RK FLAMM, RN JONES

Antimicrobial Activity of PTK[removed]Omadacycline) Tested against Gram-positive Organisms Isolated from European Hospitals in 2011 P1450 ECCMID[removed]HS SADER, RK FLAMM, RN JONES

Add to Reading List

Source URL: www.paratekpharm.com

Language: English - Date: 2012-10-12 16:04:00